ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SLS SELLAS Life Sciences Group Inc

1.30
0.01 (0.78%)
Pre Market
Last Updated: 13:04:18
Delayed by 15 minutes
Share Name Share Symbol Market Type
SELLAS Life Sciences Group Inc NASDAQ:SLS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.01 0.78% 1.30 1.30 1.33 1,167 13:04:18

Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014

29/07/2014 12:05pm

GlobeNewswire Inc.


SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more SELLAS Life Sciences Charts.

Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that the Company will report its second quarter financial results on Monday, August 11, 2014 after the close of the financial markets. The company will host a conference call following the announcement at 2:00 p.m. P.T./5:00 pm E.T. to discuss financial and business results.

The conference call can be accessed by dialing (844) 825-4413 toll-free in the United States, or (973) 638-3403 for participants outside the U.S. The Conference ID number is: 78727492. The conference call will also be webcast live and available under the Investors section/Events and Presentations on the Company's website at www.galenabiopharma.com. The archived webcast replay will be available on the Company's website for 90 days.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit: www.galenabiopharma.com.

CONTACT: Remy Bernarda
         Vice President, Marketing & Communications
         (503) 405-8258
         rbernarda@galenabiopharma.com

1 Year SELLAS Life Sciences Chart

1 Year SELLAS Life Sciences Chart

1 Month SELLAS Life Sciences Chart

1 Month SELLAS Life Sciences Chart

Your Recent History

Delayed Upgrade Clock